Tenon Medical, Inc. Selling and Marketing Expense
Tenon Medical, Inc. (TNON) reported Selling and Marketing Expense of $1.87 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:SellingAndMarketingExpense · last filed 2026-08-13
- Tenon Medical, Inc. selling and marketing expense for the quarter ending 2026-06-30 was $1.87M, a 67.02% increase year-over-year.
- Tenon Medical, Inc. selling and marketing expense for the quarter ending 2026-03-31 was $1.86M, a 12.81% increase year-over-year.
- Tenon Medical, Inc. selling and marketing expense for the quarter ending 2025-12-31 was $1.72M, a 61.24% increase year-over-year.
- Tenon Medical, Inc. selling and marketing expense for the quarter ending 2025-09-30 was $1.54M, a 26.90% increase year-over-year.
- Tenon Medical, Inc. selling and marketing expense for fiscal 2025 was $6.03M, a 17.95% increase from fiscal 2024.
- Tenon Medical, Inc. selling and marketing expense for fiscal 2024 was $5.11M, a 24.62% decline from fiscal 2023.
- Tenon Medical, Inc. selling and marketing expense for fiscal 2023 was $6.78M, a 13.47% decline from fiscal 2022.
- Tenon Medical, Inc. selling and marketing expense for fiscal 2022 was $7.83M, a 265.86% increase from fiscal 2021.
| Period end | Selling and Marketing Expense 3 month | Selling and Marketing Expense 6 month | Selling and Marketing Expense 9 month | Selling and Marketing Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $1.87M 10-Q · filed 2026-08-13 | $3.73M 10-Q · filed 2026-08-13 | $5.45M derived: sum of 3 quarters · filed 2026-08-13 | $6.99M derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-03-31 | $1.86M 10-Q · filed 2026-05-15 | $3.58M derived: sum of 2 quarters · filed 2026-05-15 | $5.12M derived: sum of 3 quarters · filed 2026-05-15 | $6.24M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-12-31 | $1.72M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-27 | $3.26M derived: sum of 2 quarters · filed 2026-03-27 | $4.38M derived: sum of 3 quarters · filed 2026-08-13 | $6.03M 10-K · filed 2026-03-27 |
| 2025-09-30 | $1.54M 10-Q · filed 2025-11-13 | $2.66M derived: sum of 2 quarters · filed 2026-08-13 | $4.30M 10-Q · filed 2025-11-13 | $5.37M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-06-30 | $1.12M 10-Q · filed 2026-08-13 | $2.77M 10-Q · filed 2026-08-13 | $3.83M derived: sum of 3 quarters · filed 2026-08-13 | $5.05M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-03-31 | $1.65M 10-Q · filed 2026-05-15 | $2.71M derived: sum of 2 quarters · filed 2026-05-15 | $3.93M derived: sum of 3 quarters · filed 2026-05-15 | $5.38M derived: sum of 4 quarters · filed 2026-05-15 |
| 2024-12-31 | $1.07M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-27 | $2.28M derived: sum of 2 quarters · filed 2026-03-27 | $3.73M derived: sum of 3 quarters · filed 2026-03-27 | $5.11M 10-K · filed 2026-03-27 |
| 2024-09-30 | $1.21M 10-Q · filed 2025-11-13 | $2.66M derived: sum of 2 quarters · filed 2025-11-13 | $4.04M 10-Q · filed 2025-11-13 | $5.38M derived: sum of 4 quarters · filed 2025-11-13 |
| 2024-06-30 | $1.45M 10-Q · filed 2025-08-13 | $2.83M 10-Q · filed 2025-08-13 | $4.17M derived: sum of 3 quarters · filed 2025-08-13 | $5.70M derived: sum of 4 quarters · filed 2025-08-13 |
| 2024-03-31 | $1.38M 10-Q · filed 2025-05-13 | $2.72M derived: sum of 2 quarters · filed 2025-05-13 | $4.25M derived: sum of 3 quarters · filed 2025-05-13 | $6.13M derived: sum of 4 quarters · filed 2025-05-13 |
| 2023-12-31 | $1.34M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-26 | $2.87M derived: sum of 2 quarters · filed 2025-03-26 | $4.75M derived: sum of 3 quarters · filed 2025-03-26 | $6.78M 10-K · filed 2025-03-26 |
| 2023-09-30 | $1.53M 10-Q · filed 2024-11-14 | $3.41M derived: sum of 2 quarters · filed 2024-11-14 | $5.44M 10-Q · filed 2024-11-14 | $10.40M derived: sum of 4 quarters · filed 2024-11-14 |
| 2023-06-30 | $1.88M 10-Q · filed 2024-08-13 | $3.91M 10-Q · filed 2024-08-13 | $8.88M derived: sum of 3 quarters · filed 2024-08-13 | $9.52M derived: sum of 4 quarters · filed 2024-08-13 |
| 2023-03-31 | $2.03M 10-Q · filed 2024-05-15 | $7.00M derived: sum of 2 quarters · filed 2024-05-15 | $7.64M derived: sum of 3 quarters · filed 2024-05-15 | $9.58M derived: sum of 4 quarters · filed 2024-05-15 |
| 2022-12-31 | $4.97M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-29 | $5.61M derived: sum of 2 quarters · filed 2024-03-29 | $7.56M derived: sum of 3 quarters · filed 2024-03-29 | $7.83M 10-K · filed 2024-03-29 |
| 2022-09-30 | $645.00K 10-Q · filed 2023-11-14 | $2.59M derived: sum of 2 quarters · filed 2023-11-14 | $2.86M 10-Q · filed 2023-11-14 | $3.53M derived: sum of 4 quarters · filed 2023-11-14 |
| 2022-06-30 | $1.94M 10-Q · filed 2023-08-11 | $2.22M 10-Q · filed 2023-08-11 | $2.89M derived: sum of 3 quarters · filed 2023-08-11 | $3.44M derived: sum of 4 quarters · filed 2023-08-11 |
| 2022-03-31 | $276.00K 10-Q · filed 2023-05-09 | $944.00K derived: sum of 2 quarters · filed 2023-05-09 | $1.50M derived: sum of 3 quarters · filed 2023-05-09 | $2.41M derived: sum of 4 quarters · filed 2023-05-09 |
| 2021-12-31 | $668.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-10 | $1.22M derived: sum of 2 quarters · filed 2023-03-10 | $2.14M derived: sum of 3 quarters · filed 2023-03-10 | $2.14M 10-K · filed 2023-03-10 |
| 2021-09-30 | $556.00K 10-Q · filed 2022-11-10 | $1.47M derived: sum of 2 quarters · filed 2022-11-10 | $1.47M 10-Q · filed 2022-11-10 | |
| 2021-06-30 | $913.00K 10-Q · filed 2022-08-12 | $917.00K 10-Q · filed 2022-08-12 | ||
| 2021-03-31 | $4.00K 10-Q · filed 2022-06-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Profusa, Inc. (PFSA) | United States | $0.002B | |
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |